SCHEMBL7671891

SCHEMBL7671891

CCCCC[C@@H](/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)NCOC)[C@@H](O[Si](C)(C)C(C)(C)C)C[C@H]1O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 5/20 0.51
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 1/20 0.44
HKDC1 Q2TB90 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
SAE1 Q9UBE0 1/20 0.44
UBA2 Q9UBT2 1/20 0.44
TBXA2R P21731 6/20 0.40
LMNA P02545 4/20 0.40
PTGER1 P34995 1/20 0.40
PTGER4 P35408 1/20 0.40
PTGFR P43088 1/20 0.40
PTGER3 P43115 1/20 0.40
PTGDR Q13258 1/20 0.40
SLCO2A1 Q92959 1/20 0.40
HPGD P15428 2/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
HIF1A Q16665 1/20 0.39
CA2 P00918 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7671897 1.00 PDE4D (0.51) PDE4DALDH1A1KDM4EHKDC1TDP1
SCHEMBL7671311 0.90 PDE4D (0.62) PDE4DALDH1A1KDM4EHKDC1TDP1
SCHEMBL7671298 0.90 PDE4D (0.62) PDE4DALDH1A1KDM4EHKDC1TDP1
SCHEMBL7671306 0.90 PDE4D (0.62) PDE4DALDH1A1KDM4EHKDC1TDP1
SCHEMBL7673838 0.88 PDE4D (0.53) PDE4DALDH1A1KDM4EHKDC1TDP1
SCHEMBL7673833 0.88 PDE4D (0.53) PDE4DALDH1A1KDM4EHKDC1TDP1
SCHEMBL7673843 0.88 PDE4D (0.53) PDE4DALDH1A1KDM4EHKDC1TDP1
SCHEMBL7959524 0.86 PDE4D (0.49) PDE4DALDH1A1KDM4EHKDC1TDP1
SCHEMBL7959521 0.86 PDE4D (0.49) PDE4DALDH1A1KDM4EHKDC1TDP1
SCHEMBL7959518 0.86 PDE4D (0.49) PDE4DALDH1A1KDM4EHKDC1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6359181-B1 THERAPY FOR VISION DEFECTS ALLERGAN SALES, INC. 2002-03-19 US disclosed
US-6307092-B1 POTENT OCULAR HYPOTENSIVES AND ARE PARTICULARLY SUITED FOR THE MANAGEMENT OF GLAUCOMA. ALLERGAN SALES, INC. 2001-10-23 US disclosed
US-6248783-B1 GLAUCOMA THERAPY ALLERGAN SALES, INC. 2001-06-19 US disclosed